

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 7.41890680 |
| 2 | central nervous system myelination (GO:0022010) | 7.41890680 |
| 3 | fatty acid elongation (GO:0030497) | 4.37200458 |
| 4 | myelination (GO:0042552) | 4.31058683 |
| 5 | axon ensheathment (GO:0008366) | 4.27078244 |
| 6 | ensheathment of neurons (GO:0007272) | 4.27078244 |
| 7 | presynaptic membrane organization (GO:0097090) | 4.07345010 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.99971146 |
| 9 | synaptic vesicle maturation (GO:0016188) | 3.98554815 |
| 10 | L-amino acid import (GO:0043092) | 3.98027752 |
| 11 | negative regulation of neurotransmitter transport (GO:0051589) | 3.95287995 |
| 12 | neuron cell-cell adhesion (GO:0007158) | 3.94075030 |
| 13 | neuronal action potential propagation (GO:0019227) | 3.91005658 |
| 14 | presynaptic membrane assembly (GO:0097105) | 3.87740518 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.83922462 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.83066757 |
| 17 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.81620733 |
| 18 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.76010558 |
| 19 | locomotory exploration behavior (GO:0035641) | 3.71926101 |
| 20 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.71113703 |
| 21 | transmission of nerve impulse (GO:0019226) | 3.69668486 |
| 22 | cerebellar granule cell differentiation (GO:0021707) | 3.69555544 |
| 23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.62764911 |
| 24 | vocalization behavior (GO:0071625) | 3.61841081 |
| 25 | synaptic vesicle exocytosis (GO:0016079) | 3.59696638 |
| 26 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.58383503 |
| 27 | dendritic spine morphogenesis (GO:0060997) | 3.53900422 |
| 28 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.49392980 |
| 29 | protein localization to synapse (GO:0035418) | 3.46632588 |
| 30 | adult walking behavior (GO:0007628) | 3.45890224 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.41222969 |
| 32 | establishment of mitochondrion localization (GO:0051654) | 3.39553028 |
| 33 | postsynaptic membrane organization (GO:0001941) | 3.38179472 |
| 34 | eye photoreceptor cell differentiation (GO:0001754) | 3.35990432 |
| 35 | photoreceptor cell differentiation (GO:0046530) | 3.35990432 |
| 36 | neuron recognition (GO:0008038) | 3.29671656 |
| 37 | synaptic transmission, glutamatergic (GO:0035249) | 3.29012593 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 3.28172579 |
| 39 | glutamate secretion (GO:0014047) | 3.27834050 |
| 40 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.23763184 |
| 41 | gamma-aminobutyric acid transport (GO:0015812) | 3.23572792 |
| 42 | apical protein localization (GO:0045176) | 3.22076226 |
| 43 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.20767520 |
| 44 | neuronal ion channel clustering (GO:0045161) | 3.18473335 |
| 45 | negative regulation of protein localization to cell surface (GO:2000009) | 3.18302242 |
| 46 | nucleobase catabolic process (GO:0046113) | 3.16490779 |
| 47 | limb bud formation (GO:0060174) | 3.14097271 |
| 48 | cellular potassium ion homeostasis (GO:0030007) | 3.08579811 |
| 49 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.07297171 |
| 50 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.05494639 |
| 51 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.04942234 |
| 52 | dendrite morphogenesis (GO:0048813) | 3.03577208 |
| 53 | axonal fasciculation (GO:0007413) | 3.02878078 |
| 54 | amino acid import (GO:0043090) | 3.02306209 |
| 55 | regulation of synaptic vesicle transport (GO:1902803) | 3.02171706 |
| 56 | layer formation in cerebral cortex (GO:0021819) | 3.01283071 |
| 57 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.99676653 |
| 58 | neuron remodeling (GO:0016322) | 2.98842582 |
| 59 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.98528929 |
| 60 | asymmetric protein localization (GO:0008105) | 2.97127723 |
| 61 | oligodendrocyte differentiation (GO:0048709) | 2.96651254 |
| 62 | glycine transport (GO:0015816) | 2.95582160 |
| 63 | mating behavior (GO:0007617) | 2.93735902 |
| 64 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.93148320 |
| 65 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.92937493 |
| 66 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.92424515 |
| 67 | response to methylmercury (GO:0051597) | 2.90631384 |
| 68 | myelin maintenance (GO:0043217) | 2.90331212 |
| 69 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.90065113 |
| 70 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.89407675 |
| 71 | auditory behavior (GO:0031223) | 2.86630515 |
| 72 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.86614726 |
| 73 | positive regulation of membrane potential (GO:0045838) | 2.86304010 |
| 74 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.86035518 |
| 75 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.85773609 |
| 76 | neurotransmitter secretion (GO:0007269) | 2.82210595 |
| 77 | long-term memory (GO:0007616) | 2.79897438 |
| 78 | response to pheromone (GO:0019236) | 2.79872773 |
| 79 | membrane hyperpolarization (GO:0060081) | 2.78340245 |
| 80 | mechanosensory behavior (GO:0007638) | 2.78295679 |
| 81 | neurotransmitter uptake (GO:0001504) | 2.77525563 |
| 82 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.76907237 |
| 83 | glycerophospholipid catabolic process (GO:0046475) | 2.75905831 |
| 84 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.75604670 |
| 85 | exploration behavior (GO:0035640) | 2.74949843 |
| 86 | regulation of collateral sprouting (GO:0048670) | 2.74353775 |
| 87 | regulation of postsynaptic membrane potential (GO:0060078) | 2.74177754 |
| 88 | neurotransmitter transport (GO:0006836) | 2.73244036 |
| 89 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.70416757 |
| 90 | negative regulation of axonogenesis (GO:0050771) | 2.70088180 |
| 91 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.66887948 |
| 92 | regulation of neurotransmitter secretion (GO:0046928) | 2.65003625 |
| 93 | long-term synaptic potentiation (GO:0060291) | 2.63673540 |
| 94 | import into cell (GO:0098657) | 2.63605290 |
| 95 | * cerebral cortex radially oriented cell migration (GO:0021799) | 2.62552247 |
| 96 | retinal ganglion cell axon guidance (GO:0031290) | 2.59816300 |
| 97 | potassium ion import (GO:0010107) | 2.59351660 |
| 98 | behavioral response to cocaine (GO:0048148) | 2.58898859 |
| 99 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.58889878 |
| 100 | potassium ion homeostasis (GO:0055075) | 2.58801333 |
| 101 | synapse assembly (GO:0007416) | 2.56651755 |
| 102 | neuromuscular process controlling posture (GO:0050884) | 2.56608119 |
| 103 | dendritic spine organization (GO:0097061) | 2.56582454 |
| 104 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.55174978 |
| 105 | regulation of dendritic spine development (GO:0060998) | 2.55007273 |
| 106 | neuromuscular process controlling balance (GO:0050885) | 2.54534238 |
| 107 | cell differentiation in hindbrain (GO:0021533) | 2.54005415 |
| 108 | axon extension (GO:0048675) | 2.53709468 |
| 109 | regulation of neurotransmitter transport (GO:0051588) | 2.53474137 |
| 110 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.53029610 |
| 111 | substantia nigra development (GO:0021762) | 2.52552811 |
| 112 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.50650727 |
| 113 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.50641075 |
| 114 | otic vesicle formation (GO:0030916) | 2.48674334 |
| 115 | positive regulation of dendritic spine development (GO:0060999) | 2.45426946 |
| 116 | limb development (GO:0060173) | 2.44322219 |
| 117 | appendage development (GO:0048736) | 2.44322219 |
| 118 | positive regulation of synapse assembly (GO:0051965) | 2.42171812 |
| 119 | regulation of synapse assembly (GO:0051963) | 2.38513698 |
| 120 | regulation of synapse structural plasticity (GO:0051823) | 2.36973116 |
| 121 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.36047893 |
| 122 | establishment of nucleus localization (GO:0040023) | 2.35491640 |
| 123 | cell communication by electrical coupling (GO:0010644) | 2.29757534 |
| 124 | neuromuscular synaptic transmission (GO:0007274) | 2.29607121 |
| 125 | somite development (GO:0061053) | 2.29585036 |
| 126 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.29105547 |
| 127 | spinal cord development (GO:0021510) | 2.28423572 |
| 128 | positive regulation of synapse maturation (GO:0090129) | 2.28413155 |
| 129 | membrane depolarization during action potential (GO:0086010) | 2.28391079 |
| 130 | cell migration in hindbrain (GO:0021535) | 2.26955564 |
| 131 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.25572454 |
| 132 | cochlea development (GO:0090102) | 2.23105352 |
| 133 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.22567733 |
| 134 | regulation of membrane repolarization (GO:0060306) | 2.22034053 |
| 135 | startle response (GO:0001964) | 2.20166703 |
| 136 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.19989608 |
| 137 | membrane assembly (GO:0071709) | 2.18283363 |
| 138 | central nervous system neuron axonogenesis (GO:0021955) | 2.18024872 |
| 139 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.17412772 |
| 140 | neuron projection extension (GO:1990138) | 2.17208642 |
| 141 | cell communication involved in cardiac conduction (GO:0086065) | 2.16115731 |
| 142 | synapse organization (GO:0050808) | 2.15867520 |
| 143 | axon extension involved in axon guidance (GO:0048846) | 2.15623500 |
| 144 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.15623500 |
| 145 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.15300519 |
| 146 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.14976879 |
| 147 | peripheral nervous system axon ensheathment (GO:0032292) | 2.13839329 |
| 148 | myelination in peripheral nervous system (GO:0022011) | 2.13839329 |
| 149 | regulation of axon guidance (GO:1902667) | 2.13113399 |
| 150 | regulation of cell communication by electrical coupling (GO:0010649) | 2.12953707 |
| 151 | innervation (GO:0060384) | 2.12938779 |
| 152 | regulation of synapse organization (GO:0050807) | 2.11301072 |
| 153 | positive regulation of potassium ion transport (GO:0043268) | 2.10852575 |
| 154 | nonmotile primary cilium assembly (GO:0035058) | 2.10645602 |
| 155 | myotube differentiation (GO:0014902) | 2.08881131 |
| 156 | artery development (GO:0060840) | 2.08669465 |
| 157 | C4-dicarboxylate transport (GO:0015740) | 2.08526885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.19627640 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.55752992 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.77127271 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.76765587 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.67069171 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.43137821 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.43137821 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.33888258 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.28759482 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.28648622 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.27256641 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.26490437 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.24748399 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.23539062 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.18888543 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.12735091 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10747283 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.10520244 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07844478 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.04806775 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.01660228 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.98746936 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.98286392 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.93902623 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.90994154 |
| 26 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.89198059 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.84699115 |
| 28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.81701529 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.80152899 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68340484 |
| 31 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66802108 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.61009083 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60433502 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.56941303 |
| 35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54931925 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52607737 |
| 37 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50852001 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50059391 |
| 39 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.49810328 |
| 40 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.47597677 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.46801326 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.46536178 |
| 43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45384463 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44011120 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42347179 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41672746 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41601810 |
| 48 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37610133 |
| 49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36423633 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36376002 |
| 51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36191332 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.32140213 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32007972 |
| 54 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.30839829 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29850628 |
| 56 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.29700225 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26792483 |
| 58 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24833206 |
| 59 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.22944714 |
| 60 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20019888 |
| 61 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.18170379 |
| 62 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16740786 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16386679 |
| 64 | FUS_26573619_Chip-Seq_HEK293_Human | 1.16194171 |
| 65 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16018582 |
| 66 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15986139 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15885152 |
| 68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15803129 |
| 69 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15648077 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15623288 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15405252 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15125517 |
| 73 | EWS_26573619_Chip-Seq_HEK293_Human | 1.14381579 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12384553 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11863786 |
| 76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.10622038 |
| 77 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10585726 |
| 78 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.10090234 |
| 79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09066759 |
| 80 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.08643033 |
| 81 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08395287 |
| 82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08376418 |
| 83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07722889 |
| 84 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07424792 |
| 85 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.07339679 |
| 86 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.07282734 |
| 87 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07033955 |
| 88 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07018725 |
| 89 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.06872965 |
| 90 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06063469 |
| 91 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04003694 |
| 92 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02779915 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02665223 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02515012 |
| 95 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.02427090 |
| 96 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.01743375 |
| 97 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.01123772 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00623327 |
| 99 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00219527 |
| 100 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99733506 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99375076 |
| 102 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99152876 |
| 103 | AR_19668381_ChIP-Seq_PC3_Human | 0.99111161 |
| 104 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96975765 |
| 105 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95147683 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95147683 |
| 107 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95108204 |
| 108 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94471492 |
| 109 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93221150 |
| 110 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.92835934 |
| 111 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92314040 |
| 112 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90655301 |
| 113 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90506762 |
| 114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89810933 |
| 115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89810933 |
| 116 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89421160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.46898353 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.41944850 |
| 3 | MP0004270_analgesia | 3.62152514 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.17304972 |
| 5 | MP0000920_abnormal_myelination | 3.09318280 |
| 6 | MP0009046_muscle_twitch | 2.92661710 |
| 7 | MP0002064_seizures | 2.86611493 |
| 8 | MP0002272_abnormal_nervous_system | 2.83896833 |
| 9 | MP0009745_abnormal_behavioral_response | 2.81600638 |
| 10 | MP0001486_abnormal_startle_reflex | 2.81059117 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.76611437 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.48196035 |
| 13 | MP0004885_abnormal_endolymph | 2.34640270 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.30397485 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.29466221 |
| 16 | MP0003329_amyloid_beta_deposits | 2.25910511 |
| 17 | MP0000778_abnormal_nervous_system | 2.14623972 |
| 18 | MP0005551_abnormal_eye_electrophysiolog | 2.10935250 |
| 19 | MP0003690_abnormal_glial_cell | 2.07567826 |
| 20 | MP0004742_abnormal_vestibular_system | 2.05710408 |
| 21 | MP0001529_abnormal_vocalization | 1.96714725 |
| 22 | MP0001968_abnormal_touch/_nociception | 1.95358451 |
| 23 | MP0002822_catalepsy | 1.91831112 |
| 24 | MP0001440_abnormal_grooming_behavior | 1.89530767 |
| 25 | MP0004142_abnormal_muscle_tone | 1.81669298 |
| 26 | MP0008569_lethality_at_weaning | 1.81178544 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.79224110 |
| 28 | MP0001905_abnormal_dopamine_level | 1.74249866 |
| 29 | MP0005171_absent_coat_pigmentation | 1.72305414 |
| 30 | MP0002229_neurodegeneration | 1.67350824 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.64831894 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.64338849 |
| 33 | MP0001485_abnormal_pinna_reflex | 1.63240830 |
| 34 | MP0003634_abnormal_glial_cell | 1.62206262 |
| 35 | MP0000955_abnormal_spinal_cord | 1.61038483 |
| 36 | MP0010030_abnormal_orbit_morphology | 1.60706865 |
| 37 | MP0004924_abnormal_behavior | 1.58884657 |
| 38 | MP0005386_behavior/neurological_phenoty | 1.58884657 |
| 39 | MP0002882_abnormal_neuron_morphology | 1.58878196 |
| 40 | MP0001970_abnormal_pain_threshold | 1.57212307 |
| 41 | MP0002184_abnormal_innervation | 1.53372327 |
| 42 | MP0002102_abnormal_ear_morphology | 1.50493229 |
| 43 | MP0005409_darkened_coat_color | 1.49961106 |
| 44 | MP0002736_abnormal_nociception_after | 1.47254685 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.47165611 |
| 46 | MP0003632_abnormal_nervous_system | 1.43707525 |
| 47 | MP0002066_abnormal_motor_capabilities/c | 1.42878963 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.42287115 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.40673530 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.40661662 |
| 51 | MP0002638_abnormal_pupillary_reflex | 1.39149446 |
| 52 | MP0003136_yellow_coat_color | 1.38740907 |
| 53 | MP0003633_abnormal_nervous_system | 1.38307412 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.36738906 |
| 55 | MP0003631_nervous_system_phenotype | 1.36403761 |
| 56 | MP0005503_abnormal_tendon_morphology | 1.29736218 |
| 57 | MP0004043_abnormal_pH_regulation | 1.28317018 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 1.26268643 |
| 59 | MP0005646_abnormal_pituitary_gland | 1.26239304 |
| 60 | MP0003283_abnormal_digestive_organ | 1.24549695 |
| 61 | MP0005410_abnormal_fertilization | 1.23568066 |
| 62 | MP0004215_abnormal_myocardial_fiber | 1.21157456 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.21058703 |
| 64 | MP0001502_abnormal_circadian_rhythm | 1.20930218 |
| 65 | MP0005187_abnormal_penis_morphology | 1.20583996 |
| 66 | MP0006292_abnormal_olfactory_placode | 1.20160423 |
| 67 | MP0001963_abnormal_hearing_physiology | 1.19137993 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 1.18921920 |
| 69 | MP0002234_abnormal_pharynx_morphology | 1.17662134 |
| 70 | MP0002938_white_spotting | 1.17476602 |
| 71 | MP0006072_abnormal_retinal_apoptosis | 1.17390527 |
| 72 | MP0002752_abnormal_somatic_nervous | 1.17269821 |
| 73 | MP0001984_abnormal_olfaction | 1.15194490 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.12800901 |
| 75 | MP0005253_abnormal_eye_physiology | 1.12470201 |
| 76 | MP0006276_abnormal_autonomic_nervous | 1.10210329 |
| 77 | MP0002152_abnormal_brain_morphology | 1.09154953 |
| 78 | MP0001299_abnormal_eye_distance/ | 1.08859164 |
| 79 | MP0000049_abnormal_middle_ear | 1.07664542 |
| 80 | MP0003937_abnormal_limbs/digits/tail_de | 1.06620438 |
| 81 | MP0001177_atelectasis | 1.06291173 |
| 82 | MP0002233_abnormal_nose_morphology | 1.04170230 |
| 83 | MP0000604_amyloidosis | 1.00800805 |
| 84 | MP0003385_abnormal_body_wall | 1.00233278 |
| 85 | MP0005195_abnormal_posterior_eye | 1.00040843 |
| 86 | MP0000749_muscle_degeneration | 0.97663056 |
| 87 | MP0000534_abnormal_ureter_morphology | 0.95110315 |
| 88 | MP0003755_abnormal_palate_morphology | 0.93280171 |
| 89 | MP0004084_abnormal_cardiac_muscle | 0.92662636 |
| 90 | MP0010368_abnormal_lymphatic_system | 0.92538245 |
| 91 | MP0001188_hyperpigmentation | 0.92379297 |
| 92 | MP0008438_abnormal_cutaneous_collagen | 0.92160275 |
| 93 | MP0003787_abnormal_imprinting | 0.91662572 |
| 94 | MP0002108_abnormal_muscle_morphology | 0.89322639 |
| 95 | MP0003890_abnormal_embryonic-extraembry | 0.88052242 |
| 96 | MP0004272_abnormal_basement_membrane | 0.87767487 |
| 97 | MP0003121_genomic_imprinting | 0.87502120 |
| 98 | MP0003942_abnormal_urinary_system | 0.87388424 |
| 99 | MP0000566_synostosis | 0.86124524 |
| 100 | MP0001293_anophthalmia | 0.85754064 |
| 101 | MP0002090_abnormal_vision | 0.85615464 |
| 102 | MP0009250_abnormal_appendicular_skeleto | 0.84840939 |
| 103 | MP0005623_abnormal_meninges_morphology | 0.84099073 |
| 104 | MP0000428_abnormal_craniofacial_morphol | 0.83962761 |
| 105 | MP0003879_abnormal_hair_cell | 0.83704690 |
| 106 | MP0005620_abnormal_muscle_contractility | 0.82770629 |
| 107 | MP0000631_abnormal_neuroendocrine_gland | 0.82737889 |
| 108 | MP0005394_taste/olfaction_phenotype | 0.82033796 |
| 109 | MP0005499_abnormal_olfactory_system | 0.82033796 |
| 110 | MP0000026_abnormal_inner_ear | 0.81427798 |
| 111 | MP0003122_maternal_imprinting | 0.81099844 |
| 112 | MP0002653_abnormal_ependyma_morphology | 0.79112163 |
| 113 | MP0002751_abnormal_autonomic_nervous | 0.78811272 |
| 114 | MP0004134_abnormal_chest_morphology | 0.78310697 |
| 115 | MP0005275_abnormal_skin_tensile | 0.77565227 |
| 116 | MP0000462_abnormal_digestive_system | 0.77434430 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.76376329 |
| 118 | MP0010678_abnormal_skin_adnexa | 0.74638852 |
| 119 | MP0004085_abnormal_heartbeat | 0.73970673 |
| 120 | MP0002909_abnormal_adrenal_gland | 0.68202200 |
| 121 | MP0004858_abnormal_nervous_system | 0.66817025 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.66365894 |
| 123 | MP0001346_abnormal_lacrimal_gland | 0.63512271 |
| 124 | MP0000013_abnormal_adipose_tissue | 0.63247582 |
| 125 | MP0003195_calcinosis | 0.62073554 |
| 126 | MP0001943_abnormal_respiration | 0.61456227 |
| 127 | MP0003938_abnormal_ear_development | 0.61347936 |
| 128 | MP0001664_abnormal_digestion | 0.61001988 |
| 129 | MP0003861_abnormal_nervous_system | 0.60031507 |
| 130 | MP0008874_decreased_physiological_sensi | 0.56512788 |
| 131 | MP0004147_increased_porphyrin_level | 0.56427794 |
| 132 | MP0000747_muscle_weakness | 0.55418844 |
| 133 | MP0000003_abnormal_adipose_tissue | 0.54740730 |
| 134 | MP0000751_myopathy | 0.51524504 |
| 135 | MP0005535_abnormal_body_temperature | 0.50874611 |
| 136 | MP0008872_abnormal_physiological_respon | 0.50339240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.91085692 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.91085692 |
| 3 | Focal motor seizures (HP:0011153) | 4.88164782 |
| 4 | Neurofibrillary tangles (HP:0002185) | 4.85993234 |
| 5 | Myokymia (HP:0002411) | 4.78310597 |
| 6 | Abnormality of the corticospinal tract (HP:0002492) | 4.33304130 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 3.76724020 |
| 8 | Focal seizures (HP:0007359) | 3.74811071 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.73027779 |
| 10 | Action tremor (HP:0002345) | 3.58890783 |
| 11 | Scanning speech (HP:0002168) | 3.54549411 |
| 12 | Intention tremor (HP:0002080) | 3.50573205 |
| 13 | Epileptic encephalopathy (HP:0200134) | 3.48578397 |
| 14 | Dysmetria (HP:0001310) | 3.48126609 |
| 15 | Spastic gait (HP:0002064) | 3.30407204 |
| 16 | Atonic seizures (HP:0010819) | 3.22144661 |
| 17 | Termporal pattern (HP:0011008) | 3.17767027 |
| 18 | Insidious onset (HP:0003587) | 3.17767027 |
| 19 | Peripheral hypomyelination (HP:0007182) | 3.17417220 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 3.13170497 |
| 21 | Ankle clonus (HP:0011448) | 3.08581453 |
| 22 | Broad-based gait (HP:0002136) | 3.01431487 |
| 23 | Dysdiadochokinesis (HP:0002075) | 2.90847839 |
| 24 | Hyperventilation (HP:0002883) | 2.85818010 |
| 25 | Gaze-evoked nystagmus (HP:0000640) | 2.84583151 |
| 26 | Sensory axonal neuropathy (HP:0003390) | 2.82404636 |
| 27 | Onion bulb formation (HP:0003383) | 2.80608275 |
| 28 | Alacrima (HP:0000522) | 2.74443917 |
| 29 | Dialeptic seizures (HP:0011146) | 2.63393539 |
| 30 | Absence seizures (HP:0002121) | 2.60453416 |
| 31 | Visual hallucinations (HP:0002367) | 2.60211349 |
| 32 | Retinal dysplasia (HP:0007973) | 2.58935879 |
| 33 | Septo-optic dysplasia (HP:0100842) | 2.55473830 |
| 34 | Thickened helices (HP:0000391) | 2.47491955 |
| 35 | Parakeratosis (HP:0001036) | 2.47032840 |
| 36 | Megalencephaly (HP:0001355) | 2.47025223 |
| 37 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.43898449 |
| 38 | Aplasia of the phalanges of the hand (HP:0009802) | 2.43898449 |
| 39 | Aplasia involving bones of the extremities (HP:0009825) | 2.43898449 |
| 40 | Abnormal auditory evoked potentials (HP:0006958) | 2.43856913 |
| 41 | Truncal ataxia (HP:0002078) | 2.42479064 |
| 42 | Generalized tonic-clonic seizures (HP:0002069) | 2.41100216 |
| 43 | Hemiparesis (HP:0001269) | 2.34634109 |
| 44 | Pheochromocytoma (HP:0002666) | 2.33953891 |
| 45 | Febrile seizures (HP:0002373) | 2.32497928 |
| 46 | Lower limb muscle weakness (HP:0007340) | 2.30743366 |
| 47 | Anxiety (HP:0000739) | 2.27455200 |
| 48 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.24704860 |
| 49 | Absent/shortened dynein arms (HP:0200106) | 2.24704860 |
| 50 | Decreased lacrimation (HP:0000633) | 2.21603227 |
| 51 | Urinary urgency (HP:0000012) | 2.19376640 |
| 52 | Optic nerve hypoplasia (HP:0000609) | 2.16043197 |
| 53 | Limb dystonia (HP:0002451) | 2.15683445 |
| 54 | Anteriorly placed anus (HP:0001545) | 2.15653590 |
| 55 | Increased circulating renin level (HP:0000848) | 2.15384605 |
| 56 | Blue irides (HP:0000635) | 2.12163342 |
| 57 | Congenital primary aphakia (HP:0007707) | 2.11721140 |
| 58 | Gait imbalance (HP:0002141) | 2.07020021 |
| 59 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.06943951 |
| 60 | Postural instability (HP:0002172) | 2.06765052 |
| 61 | Vaginal atresia (HP:0000148) | 2.06260914 |
| 62 | Excessive salivation (HP:0003781) | 2.05665929 |
| 63 | Drooling (HP:0002307) | 2.05665929 |
| 64 | Akinesia (HP:0002304) | 2.04930380 |
| 65 | Abnormality of macular pigmentation (HP:0008002) | 2.03878622 |
| 66 | Genital tract atresia (HP:0001827) | 2.02510418 |
| 67 | Depression (HP:0000716) | 2.01974184 |
| 68 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.00368249 |
| 69 | Abnormality of the labia minora (HP:0012880) | 2.00333573 |
| 70 | Generalized myoclonic seizures (HP:0002123) | 1.99865805 |
| 71 | Nephrogenic diabetes insipidus (HP:0009806) | 1.99355242 |
| 72 | Central scotoma (HP:0000603) | 1.99063171 |
| 73 | Progressive inability to walk (HP:0002505) | 1.98963786 |
| 74 | Cutaneous finger syndactyly (HP:0010554) | 1.98408206 |
| 75 | Congenital stationary night blindness (HP:0007642) | 1.98104754 |
| 76 | Slow saccadic eye movements (HP:0000514) | 1.97893249 |
| 77 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.97478585 |
| 78 | Absent speech (HP:0001344) | 1.96958713 |
| 79 | Decreased central vision (HP:0007663) | 1.95830689 |
| 80 | Clonus (HP:0002169) | 1.92319761 |
| 81 | Clumsiness (HP:0002312) | 1.92155208 |
| 82 | Synostosis involving the elbow (HP:0003938) | 1.91189186 |
| 83 | Humeroradial synostosis (HP:0003041) | 1.91189186 |
| 84 | Poor eye contact (HP:0000817) | 1.90762889 |
| 85 | Limited hip movement (HP:0008800) | 1.90668343 |
| 86 | Abnormality of saccadic eye movements (HP:0000570) | 1.89897279 |
| 87 | Neuroendocrine neoplasm (HP:0100634) | 1.89807973 |
| 88 | Mutism (HP:0002300) | 1.88953609 |
| 89 | Exotropia (HP:0000577) | 1.87607717 |
| 90 | Spastic tetraparesis (HP:0001285) | 1.86736920 |
| 91 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.85845917 |
| 92 | Coronal craniosynostosis (HP:0004440) | 1.85752850 |
| 93 | Abolished electroretinogram (ERG) (HP:0000550) | 1.85668438 |
| 94 | Abnormality of the calf musculature (HP:0001430) | 1.84827353 |
| 95 | Cerebral hypomyelination (HP:0006808) | 1.84688896 |
| 96 | Abnormal eating behavior (HP:0100738) | 1.83888393 |
| 97 | Torticollis (HP:0000473) | 1.82570763 |
| 98 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.82308451 |
| 99 | Metabolic alkalosis (HP:0200114) | 1.82223793 |
| 100 | Polyphagia (HP:0002591) | 1.81552781 |
| 101 | Epileptiform EEG discharges (HP:0011182) | 1.81361422 |
| 102 | Maternal diabetes (HP:0009800) | 1.81057165 |
| 103 | Abnormal ciliary motility (HP:0012262) | 1.80694738 |
| 104 | EEG with generalized epileptiform discharges (HP:0011198) | 1.79709417 |
| 105 | Neuronal loss in central nervous system (HP:0002529) | 1.79235830 |
| 106 | Specific learning disability (HP:0001328) | 1.79049150 |
| 107 | Split foot (HP:0001839) | 1.78771226 |
| 108 | Neonatal short-limb short stature (HP:0008921) | 1.78751126 |
| 109 | Medial flaring of the eyebrow (HP:0010747) | 1.77979885 |
| 110 | Absent septum pellucidum (HP:0001331) | 1.76544349 |
| 111 | Nephronophthisis (HP:0000090) | 1.75568634 |
| 112 | Choroideremia (HP:0001139) | 1.75020246 |
| 113 | Bronchomalacia (HP:0002780) | 1.73806223 |
| 114 | Abnormal social behavior (HP:0012433) | 1.72798553 |
| 115 | Impaired social interactions (HP:0000735) | 1.72798553 |
| 116 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.72779803 |
| 117 | Abnormality of the lower motor neuron (HP:0002366) | 1.71876318 |
| 118 | Preaxial foot polydactyly (HP:0001841) | 1.71665075 |
| 119 | Poor coordination (HP:0002370) | 1.71315935 |
| 120 | True hermaphroditism (HP:0010459) | 1.70185388 |
| 121 | Rimmed vacuoles (HP:0003805) | 1.68847532 |
| 122 | Abnormality of the ischium (HP:0003174) | 1.66776100 |
| 123 | Aortic aneurysm (HP:0004942) | 1.65541927 |
| 124 | Vascular tortuosity (HP:0004948) | 1.64354552 |
| 125 | Vitreoretinal degeneration (HP:0000655) | 1.64079450 |
| 126 | Sleep apnea (HP:0010535) | 1.64076150 |
| 127 | Cutaneous syndactyly (HP:0012725) | 1.63842497 |
| 128 | Short 4th metacarpal (HP:0010044) | 1.63240694 |
| 129 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.63240694 |
| 130 | Hepatoblastoma (HP:0002884) | 1.62648399 |
| 131 | Type II lissencephaly (HP:0007260) | 1.62393720 |
| 132 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.62240173 |
| 133 | Shallow orbits (HP:0000586) | 1.59314752 |
| 134 | Arterial tortuosity (HP:0005116) | 1.57684838 |
| 135 | Neoplasm of the heart (HP:0100544) | 1.57014557 |
| 136 | Intestinal atresia (HP:0011100) | 1.56909080 |
| 137 | Soft skin (HP:0000977) | 1.55040647 |
| 138 | Broad metatarsal (HP:0001783) | 1.53409018 |
| 139 | Prolonged QT interval (HP:0001657) | 1.52141020 |
| 140 | Abnormality of the renal medulla (HP:0100957) | 1.51105164 |
| 141 | Postaxial hand polydactyly (HP:0001162) | 1.50550001 |
| 142 | Tracheomalacia (HP:0002779) | 1.50480529 |
| 143 | Short foot (HP:0001773) | 1.50470899 |
| 144 | Midline defect of the nose (HP:0004122) | 1.48442982 |
| 145 | Chronic hepatic failure (HP:0100626) | 1.47086152 |
| 146 | Wide anterior fontanel (HP:0000260) | 1.44792711 |
| 147 | Hip contracture (HP:0003273) | 1.44552464 |
| 148 | Anophthalmia (HP:0000528) | 1.42767681 |
| 149 | Increased corneal curvature (HP:0100692) | 1.42312303 |
| 150 | Keratoconus (HP:0000563) | 1.42312303 |
| 151 | Hypoplastic ischia (HP:0003175) | 1.42127823 |
| 152 | Protrusio acetabuli (HP:0003179) | 1.41948110 |
| 153 | Atrial fibrillation (HP:0005110) | 1.41819139 |
| 154 | Calf muscle hypertrophy (HP:0008981) | 1.41551014 |
| 155 | Pancreatic fibrosis (HP:0100732) | 1.41426858 |
| 156 | Abnormality of the aortic arch (HP:0012303) | 1.40914905 |
| 157 | Left ventricular hypertrophy (HP:0001712) | 1.40691476 |
| 158 | Hip dysplasia (HP:0001385) | 1.40681202 |
| 159 | Prominent supraorbital ridges (HP:0000336) | 1.40189577 |
| 160 | Abnormality of the diencephalon (HP:0010662) | 1.39678380 |
| 161 | Turricephaly (HP:0000262) | 1.38920952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.14919068 |
| 2 | OXSR1 | 3.40672485 |
| 3 | EPHA4 | 3.02160309 |
| 4 | NTRK3 | 2.56540021 |
| 5 | MARK1 | 2.43291334 |
| 6 | CASK | 2.22771331 |
| 7 | BCR | 2.13498022 |
| 8 | CDK19 | 2.13152669 |
| 9 | TNIK | 2.11249965 |
| 10 | PAK6 | 2.06296792 |
| 11 | PNCK | 1.97870126 |
| 12 | FGFR2 | 1.90982697 |
| 13 | PKN1 | 1.86817935 |
| 14 | NTRK1 | 1.84128556 |
| 15 | WNK1 | 1.79858048 |
| 16 | PRPF4B | 1.79646229 |
| 17 | UHMK1 | 1.78019521 |
| 18 | MAP3K9 | 1.76541570 |
| 19 | MAP3K4 | 1.73497915 |
| 20 | EPHB2 | 1.72575186 |
| 21 | MAPKAPK5 | 1.70210116 |
| 22 | OBSCN | 1.67261911 |
| 23 | WNK4 | 1.66510178 |
| 24 | EPHB1 | 1.62153870 |
| 25 | NTRK2 | 1.51584352 |
| 26 | LATS2 | 1.47178046 |
| 27 | CAMK2B | 1.46663705 |
| 28 | DAPK2 | 1.46232330 |
| 29 | SGK494 | 1.43480246 |
| 30 | SGK223 | 1.43480246 |
| 31 | MINK1 | 1.38736511 |
| 32 | NEK6 | 1.36643143 |
| 33 | LATS1 | 1.35809727 |
| 34 | MAP2K7 | 1.31279263 |
| 35 | PRKD3 | 1.30103313 |
| 36 | STK38L | 1.27887204 |
| 37 | CSNK1A1L | 1.26981314 |
| 38 | * CDK5 | 1.25378792 |
| 39 | PBK | 1.23273840 |
| 40 | CSNK1G2 | 1.23000755 |
| 41 | CSNK1G3 | 1.22862571 |
| 42 | CAMK2D | 1.20902620 |
| 43 | FRK | 1.17417284 |
| 44 | TYRO3 | 1.16835056 |
| 45 | AKT3 | 1.13421882 |
| 46 | CCNB1 | 1.12461150 |
| 47 | MAPK13 | 1.12123726 |
| 48 | KSR2 | 1.11826215 |
| 49 | MET | 1.11641066 |
| 50 | ROCK2 | 1.11313214 |
| 51 | CAMK2A | 1.11119342 |
| 52 | TIE1 | 1.08680057 |
| 53 | DMPK | 1.07557990 |
| 54 | ERBB3 | 1.06421410 |
| 55 | SGK2 | 1.02740519 |
| 56 | PHKG2 | 1.02396574 |
| 57 | PHKG1 | 1.02396574 |
| 58 | PAK3 | 1.02341760 |
| 59 | PIK3CA | 0.96983278 |
| 60 | EPHA3 | 0.95096168 |
| 61 | ICK | 0.94808147 |
| 62 | PINK1 | 0.93493770 |
| 63 | CAMK2G | 0.93414373 |
| 64 | MARK2 | 0.93324422 |
| 65 | FGR | 0.92615133 |
| 66 | CSNK1G1 | 0.92559207 |
| 67 | MAP2K4 | 0.92062570 |
| 68 | CDK14 | 0.90849120 |
| 69 | CDK15 | 0.87373295 |
| 70 | PLK2 | 0.86509427 |
| 71 | CDK18 | 0.85478771 |
| 72 | ARAF | 0.83758343 |
| 73 | PDGFRA | 0.83490913 |
| 74 | PRKCH | 0.83075820 |
| 75 | MYLK | 0.81976192 |
| 76 | LIMK1 | 0.81431608 |
| 77 | KSR1 | 0.77638595 |
| 78 | PRKCG | 0.77436623 |
| 79 | STK11 | 0.77390289 |
| 80 | GRK5 | 0.77193342 |
| 81 | CAMK1G | 0.76520755 |
| 82 | CDK11A | 0.75246579 |
| 83 | PRKCE | 0.73656065 |
| 84 | MUSK | 0.68995104 |
| 85 | FES | 0.68550267 |
| 86 | ROCK1 | 0.68388371 |
| 87 | TGFBR2 | 0.67833881 |
| 88 | DYRK1A | 0.67797829 |
| 89 | CAMK4 | 0.67739902 |
| 90 | WNK3 | 0.65811833 |
| 91 | CAMKK1 | 0.63000406 |
| 92 | MAP3K13 | 0.62594317 |
| 93 | PDPK1 | 0.62124479 |
| 94 | MAP3K6 | 0.59989094 |
| 95 | DDR2 | 0.58776798 |
| 96 | DYRK2 | 0.58433157 |
| 97 | MAP3K2 | 0.58371741 |
| 98 | SGK1 | 0.58122243 |
| 99 | FYN | 0.57405954 |
| 100 | BMPR2 | 0.57328107 |
| 101 | INSRR | 0.57285649 |
| 102 | FGFR1 | 0.56331999 |
| 103 | PRKG1 | 0.55245872 |
| 104 | SIK2 | 0.55179308 |
| 105 | CAMKK2 | 0.54918682 |
| 106 | SGK3 | 0.54509330 |
| 107 | PTK2B | 0.53794165 |
| 108 | PRKCQ | 0.53626643 |
| 109 | PRKAA1 | 0.53449689 |
| 110 | MAP4K2 | 0.53283219 |
| 111 | IRAK2 | 0.53204142 |
| 112 | TRIM28 | 0.51924327 |
| 113 | CAMK1 | 0.51288097 |
| 114 | BMPR1B | 0.51142544 |
| 115 | ERBB2 | 0.50599952 |
| 116 | RIPK4 | 0.50296928 |
| 117 | PRKD1 | 0.48403519 |
| 118 | MAPK15 | 0.48191758 |
| 119 | CLK1 | 0.47443600 |
| 120 | STK38 | 0.47184883 |
| 121 | PRKACA | 0.47151216 |
| 122 | CAMK1D | 0.46908231 |
| 123 | RET | 0.45215119 |
| 124 | PDK1 | 0.44852182 |
| 125 | CSNK1E | 0.43772284 |
| 126 | CSNK1D | 0.43637899 |
| 127 | PRKACB | 0.43536174 |
| 128 | CSNK1A1 | 0.41963902 |
| 129 | MAPK10 | 0.41370671 |
| 130 | RPS6KA3 | 0.40337091 |
| 131 | PRKCZ | 0.40294654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.96277939 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 2.64445237 |
| 3 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50068251 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.49064562 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.39710888 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.26920349 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 2.25984754 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.25768043 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.23546957 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.94177346 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.90817882 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.84763738 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 1.82334376 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.81508893 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.80732861 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.80244928 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.78688550 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.75114659 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.74140086 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.73797330 |
| 21 | Axon guidance_Homo sapiens_hsa04360 | 1.65923162 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.57744409 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.55301963 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53952997 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.52813554 |
| 26 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.50253212 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.48939099 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.48853329 |
| 29 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.41252799 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.39890050 |
| 31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.37959018 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.28830230 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.28618822 |
| 34 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.27469434 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.26079769 |
| 36 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.25503515 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.24204266 |
| 38 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.22868826 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 1.22624966 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21347222 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.20896330 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15728002 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.13851950 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.12890406 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11034253 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09727497 |
| 47 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.06145056 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04840710 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.02925295 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02866557 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00047675 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97845083 |
| 53 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.96468737 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94424911 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94046330 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92233938 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91883899 |
| 58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91216452 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89348992 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88703356 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87155488 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87132084 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85440921 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80965182 |
| 65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.80871118 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80011032 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 0.78240274 |
| 68 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.77658605 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77407021 |
| 70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77325589 |
| 71 | Adherens junction_Homo sapiens_hsa04520 | 0.76642574 |
| 72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75781887 |
| 73 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.75439343 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74145544 |
| 75 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.72127452 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.71641712 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71271848 |
| 78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70677836 |
| 79 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69849960 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69083454 |
| 81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66582160 |
| 82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66123759 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65829242 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64784910 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64573412 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64477583 |
| 87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.63351347 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62786811 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.62618529 |
| 90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62232403 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62179935 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62059543 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61611291 |
| 94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.60911267 |
| 95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59539794 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59350989 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58744599 |
| 98 | Tight junction_Homo sapiens_hsa04530 | 0.58332717 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56818201 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55682413 |
| 101 | Bile secretion_Homo sapiens_hsa04976 | 0.54183173 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53363617 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53245759 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.52523987 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.52239336 |
| 106 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51872495 |
| 107 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51761643 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50761588 |
| 109 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50415888 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49706524 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49187468 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48986094 |
| 113 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47945066 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | 0.46846687 |
| 115 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45882297 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45496519 |
| 117 | Glioma_Homo sapiens_hsa05214 | 0.45364914 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45105761 |
| 119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45074159 |
| 120 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44991368 |
| 121 | Alcoholism_Homo sapiens_hsa05034 | 0.44093379 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44010575 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43398195 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42020399 |
| 125 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39549456 |
| 126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36328224 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36305941 |
| 128 | Parkinsons disease_Homo sapiens_hsa05012 | 0.34058135 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33496117 |
| 130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32741976 |
| 131 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30801294 |
| 132 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30201956 |

